Access cutting-edge small cell lung cancer treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access small cell lung cancer specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell lung cancer treatment provided free
Researchers are looking for new ways to treat people with extensive-stage small cell lung cancer (SCLC) that has relapsed or is refractory. Gocatamig is a new type of immunotherapy that uses a person's immune system to find and destroy cancer cells. Ifinatamab deruxtecan (also known as I-DXd) is a drug which binds to a specific target on cancer cells and delivers treatment to destroy those cells. Durvalumab is a different type of immunotherapy that also destroys cancer cells. Researchers want to
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this small cell lung cancer clinical trial in Portland, OR
If you're searching for small cell lung cancer treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.